BioLineRx Announces Proposed Underwritten Public Offering of i...
TEL AVIV, Israel, Feb. 5, 2019 /PRNewswire-AsiaNet/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that it has commenced an underwritten public offering of American Depositary Shares ("ADSs"), each representing one ...
Authors: LATEST ASIANET NEWS RELEASES